Reduction of poly-central nervous systems medications in older adults in an integrated healthcare system: 2018-2020
J Am Geriatr Soc
.
2023 Oct;71(10):3319-3321.
doi: 10.1111/jgs.18471.
Epub 2023 Jun 23.
Authors
Eric A Lee
1
2
,
Steven G Steinberg
3
4
,
Stephen C Cheng
5
,
William L Lieu
5
,
Monica A Yoshinaga
5
,
Daniel C Powers
5
,
Michael H Kanter
2
6
,
Benjamin I Broder
4
7
Affiliations
1
Department of Internal Medicine, Southern California Permanente Medical Group, West Los Angeles, California, USA.
2
Department of Clinical Science, Kaiser Permanente-Bernard J Tyson School of Medicine, Pasadena, California, USA.
3
Department of Family Medicine, Southern California Permanente Medical Group, Panorama City, California, USA.
4
Department of Health Systems Research, Kaiser Permanente-Bernard J Tyson School of Medicine, Pasadena, California, USA.
5
Drug Use Management, Kaiser Permanente Southern California, Downey, California, USA.
6
Department of Research and Evaluation, Southern California Permanente Medical Group, Pasadena, California, USA.
7
Department of Quality and Clinical Analysis, Southern California Permanente Medical Group, Pasadena, California, USA.
PMID:
37350654
DOI:
10.1111/jgs.18471
No abstract available
Publication types
Letter
MeSH terms
Aged
Central Nervous System
Central Nervous System Agents* / therapeutic use
Delivery of Health Care, Integrated*
Drug Prescriptions
Humans
Substances
Central Nervous System Agents